AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?

The market expects AbbVie (ABBV) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2019. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.